Oviva
Switzerland · Healthtech · AI
Reimbursed digital care combining a clinical app and specialist teams for obesity and chronic conditions.
Product
Oviva provides reimbursed digital treatment for obesity and related chronic conditions. Patients use its medical-device-certified app alongside support from doctors, dietitians and behavioural specialists.
Its services reach patients through Germany’s DiGA reimbursement system, NHS partnerships in the UK and Swiss healthcare arrangements. This model lets referring clinicians offer continuing support outside an in-person appointment.
Founded in 2014 by Kai Eberhardt and Manuel Baumann, Oviva has supported more than one million patients across its three core markets, according to the company. It is expanding its treatment programmes in hypertension and type 2 diabetes.
Funding history
1 round · 0 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series D | Undisclosed | Kinnevik — LeadA.P. Moller Holding — ParticipantEGS Beteiligungen AG — ParticipantLunate — ParticipantNorrsken VC — ParticipantPlanet First Partners — ParticipantSofina — Participant |